INDV-2000 First in Human
- First Posted Date
- 2020-06-04
- Last Posted Date
- 2024-05-16
- Lead Sponsor
- Indivior Inc.
- Target Recruit Count
- 73
- Registration Number
- NCT04413552
- Locations
- 🇺🇸
Altasciences Clinical Kansas, Overland Park, Kansas, United States
SUBLOCADE Rapid Initiation Extension Study
- Conditions
- Interventions
- First Posted Date
- 2019-08-19
- Last Posted Date
- 2021-02-11
- Lead Sponsor
- Indivior Inc.
- Target Recruit Count
- 17
- Registration Number
- NCT04060654
- Locations
- 🇺🇸
Hassman Research Institute, Berlin, New Jersey, United States
SUBLOCADE Rapid Initiation Study
- First Posted Date
- 2019-06-20
- Last Posted Date
- 2022-10-03
- Lead Sponsor
- Indivior Inc.
- Target Recruit Count
- 26
- Registration Number
- NCT03993392
- Locations
- 🇺🇸
Hassman Research Institute, Berlin, New Jersey, United States
Safety, Tolerability, Pharmacokinetics and Efficacy of 180 mg Subcutaneous Risperidone From 6 mg Oral Risperidone
- First Posted Date
- 2019-06-07
- Last Posted Date
- 2021-07-07
- Lead Sponsor
- Indivior Inc.
- Target Recruit Count
- 69
- Registration Number
- NCT03978832
- Locations
- 🇺🇸
Collaborative Neuroscience Network, Garden Grove, California, United States
Evaluation of Long-term Buprenorphine Plasma Exposure
- Conditions
- Interventions
- First Posted Date
- 2018-11-26
- Last Posted Date
- 2020-08-21
- Lead Sponsor
- Indivior Inc.
- Target Recruit Count
- 53
- Registration Number
- NCT03752528
- Locations
- 🇺🇸
Pathway Healthcare, Hamilton, Alabama, United States
🇺🇸Pahl Research, Oklahoma City, Oklahoma, United States
🇺🇸Meridian Research, Tampa, Florida, United States
Buprenorphine-Fentanyl Interaction Study
- First Posted Date
- 2018-11-20
- Last Posted Date
- 2020-07-31
- Lead Sponsor
- Indivior Inc.
- Target Recruit Count
- 22
- Registration Number
- NCT03747341
- Locations
- 🇳🇱
Center for Human Drug Research, Leiden, The Netherlands, Netherlands
Study of a Novel Subcutaneous Depot Formulation of Buprenorphine
- Conditions
- Interventions
- First Posted Date
- 2018-10-23
- Last Posted Date
- 2019-03-04
- Lead Sponsor
- Indivior Inc.
- Target Recruit Count
- 12
- Registration Number
- NCT03715634
- Locations
- 🇬🇧
Quotient Sciences, Ruddington, Nottingham, United Kingdom
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
- Conditions
- First Posted Date
- 2018-07-30
- Last Posted Date
- 2019-04-18
- Lead Sponsor
- Indivior Inc.
- Target Recruit Count
- 534
- Registration Number
- NCT03604861
- Locations
- 🇺🇸
Woodland International Research Group, Little Rock, Arkansas, United States
🇺🇸Center for Emotional Fitness, Cherry Hill, New Jersey, United States
🇺🇸Carolina Clinical Trials, Charleston, South Carolina, United States
A Phase 1 Bioavailability Study of Arbaclofen Placarbil Modified Release Formulations in Healthy Volunteers
- First Posted Date
- 2017-02-20
- Last Posted Date
- 2018-01-17
- Lead Sponsor
- Indivior Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT03058237
- Locations
- 🇬🇧
Quotient Clinical, Ruddington, Nottingham, United Kingdom
Single Ascending Dose Study of RBP-6000
- First Posted Date
- 2016-12-26
- Last Posted Date
- 2016-12-26
- Lead Sponsor
- Indivior Inc.
- Target Recruit Count
- 48
- Registration Number
- NCT03002961
- Locations
- 🇺🇸
Vince and Associates Clinical Research, Overland Park,, Kansas, United States